InVivo’s latest enrollee brings INSPIRE study total to 15 patients — 4 notes

InVivo Therapeutics enrolled a new patient in its INSPIRE Study, testing the safety and efficacy of the Neuro-Spinal Scaffold for patients with complete thoracic AIS A spinal cord injury.

Advertisement

Here are four notes:

 

1. Portland-based Oregon Health & Science University enrolled the patient.

 

2. Jason J. Chang, MD, a neurological surgery assistant professor at Oregon Health & Science University, performed the surgery and implantation about 77 hours post-injury.

 

3. Dr. Chang serves as the site’s co-study investigator.

 

4. This patient brings the study’s total nationwide enrollment to 15 patients.

 

More articles on devices:
Medtronic’s Pat Shrader urges Congress to reform device facility inspections process — 5 insights
Amendia, Medtronic & more: 8 device company mergers, acquisitions and agreements in April 2017
Medtronic, J&J, K2M & more: 13 device company key notes

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.